Hepatitis C virus elimination programme

Gilead
Gilead launched an innovative donation programme with the goal of eliminating hepatitis C virus in Georgia.
Continue reading

Publishing the registration status of products, country-by-country

Gilead
Gilead publishes where it has filed for specific products to be registered, and when filings were successful.
Continue reading

Non-exclusive voluntary licensing to support affordability and supply

Gilead
Gilead’s early, systematic approach towards non-exclusive voluntary licensing helps efficient scale up and affordable supply of patented medicines in low- and middle-income countries.
Continue reading

Non-exclusive voluntary licensing outside of HIV/AIDS

Bristol-Myers Squibb, Gilead
Gilead and Bristol-Myers Squibb take the first moves, from companies in scope of the Access to Medicine Index 2016, outside non-exclusive voluntary licensing in HIV/AIDS.
Continue reading
Regional Business Partner Compliance Pocket Guide

Regional Business Partner Compliance Pocket Guide

Gilead
The Regional Business Partner Compliance Pocket Guide is a guide to support compliance by third parties working with Gilead.
Continue reading